CIK: 0001822947 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $116,635 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | INTRA-CELLULAR THERAPIES INC | 147,750 | $12,340 | 10.6% | $83.52 | — | COM | 46116X101 |
| TARS | TARSUS PHARMACEUTICALS INC | 173,144 | $9,587 | 8.2% | $28.11 | +61.6% | COM | 87650L103 |
| INSM | INSMED INC | 114,360 | $7,895 | 6.8% | $34.62 | +108.0% | COM PAR $.01 | 457669307 |
| AXSM | AXSOME THERAPEUTICS INC | 66,661 | $5,640 | 4.8% | $91.96 | 0.0% | COM | 05464T104 |
| XENE | XENON PHARMACEUTICALS INC | 129,291 | $5,068 | 4.3% | $39.20 | +5.5% | COM | 98420N105 |
| CGON | CG ONCOLOGY INC | 174,048 | $4,992 | 4.3% | $38.90 | -12.0% | COM | 156944100 |
| — | MERUS N V | 116,796 | $4,911 | 4.2% | $25.30 | — | COM | N5749R100 |
| — | BLUEPRINT MEDICINES CORP | 55,892 | $4,875 | 4.2% | $94.18 | — | COM | 09627Y109 |
| JANX | JANUX THERAPEUTICS INC | 90,292 | $4,834 | 4.1% | $43.50 | +21.6% | COM | 47103J105 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 244,538 | $4,096 | 3.5% | $15.99 | — | SPONSORED ADS | 152309100 |
| SLNO | SOLENO THERAPEUTICS INC | 87,629 | $3,939 | 3.4% | $51.81 | 0.0% | COM | 834203309 |
| GERN | GERON CORP | 1,074,824 | $3,805 | 3.3% | $2.61 | +52.8% | COM | 374163103 |
| ALMS | ALUMIS INC | 445,259 | $3,500 | 3.0% | $13.10 | -23.5% | COM | 022307102 |
| PRAX | PRAXIS PRECISION MEDICINES I | 44,982 | $3,462 | 3.0% | $33.00 | +119.2% | COM NEW | 74006W207 |
| TRVI | TREVI THERAPEUTICS INC | 781,489 | $3,220 | 2.8% | $2.78 | +15.2% | COM | 89532M101 |
| ELVN | ENLIVEN THERAPEUTICS INC | 141,710 | $3,188 | 2.7% | $23.16 | +11.9% | COM | 29337E102 |
| KRRO | KORRO BIO INC | 70,678 | $2,691 | 2.3% | $51.39 | 0.0% | COM | 500946108 |
| JSPR | JASPER THERAPEUTICS INC | 122,424 | $2,617 | 2.2% | $18.74 | +11.1% | COM NEW | 471871202 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 348,000 | $2,593 | 2.2% | $9.31 | 0.0% | COM NEW | 30233G209 |
| WHWK | AADI BIOSCIENCE INC | 817,939 | $2,581 | 2.2% | $2.27 | 0.0% | COM | 00032Q104 |
| ATYR | ATYR PHARMA INC | 699,730 | $2,533 | 2.2% | $3.03 | 0.0% | COM NEW | 002120202 |
| — | 89BIO INC | 317,833 | $2,485 | 2.1% | $7.82 | — | COM | 282559103 |
| TYRA | TYRA BIOSCIENCES INC | 175,063 | $2,433 | 2.1% | $17.29 | +5.0% | COM | 90240B106 |
| DNTH | DIANTHUS THERAPEUTICS INC | 106,434 | $2,320 | 2.0% | $25.71 | 0.0% | COM | 252828108 |
| — | MIND MEDICINE MINDMED INC | 330,275 | $2,299 | 2.0% | $9.40 | — | COM NEW | 60255C885 |
| EWTX | EDGEWISE THERAPEUTICS INC | 83,176 | $2,221 | 1.9% | $19.89 | +60.1% | COM | 28036F105 |
| — | SPRINGWORKS THERAPEUTICS INC | 54,692 | $1,976 | 1.7% | $32.04 | — | COM | 85205L107 |
| CNTX | CONTEXT THERAPEUTICS INC | 1,576,762 | $1,656 | 1.4% | $1.40 | +23.7% | COM | 21077P108 |
| — | PROMIS NEUROSCIENCES INC | 1,592,605 | $1,509 | 1.3% | $1.46 | — | COM NEW | 74346M406 |
| CLYM | CLIMB BIO INC | 760,225 | $1,368 | 1.2% | $6.90 | -47.6% | COM | 28658R106 |